Anthony Ofori | Medical Graduate in General Medicine | Founder, WellNest Central
Last updated: October 19, 2026
This article is for general health education and does not replace individual medical advice, diagnosis, or treatment.
An insulin injection site can become so familiar that you return to the same small patch of skin without thinking. If that area develops a thickened or rubbery lump, the change may be more than cosmetic. Insulin absorption can become less predictable, contributing to glucose readings that are difficult to explain.
The answer is not simply to increase the dose. The site itself deserves attention, along with your injection technique, glucose patterns, and the other factors that affect diabetes management.
What is lipohypertrophy?
Lipohypertrophy is a buildup or thickening of fatty tissue under the skin that can occur where insulin is repeatedly injected. Some areas are visibly raised; others are easier to feel than to see.
Diabetes UK’s guidance on injecting insulin explains why using a different spot for each injection helps prevent lumps. An injection site is a region of the body, not one repeatedly used point within that region.
Ask your diabetes nurse or clinician to show you how to inspect and feel the areas you use. Looking at the skin through clothing, or checking only whether a needle mark is visible, may miss a broader area of thickened tissue. This is a practical part of insulin review, not a judgment about how well you have managed diabetes.
Can a lump explain unexplained highs or lows?
Injecting into altered tissue may change how insulin is absorbed. The effect can make your usual dose behave less consistently. However, unexpected glucose results can also have other causes, including illness, food, activity, storage problems, and dosing mistakes.
Bring glucose records and your insulin supplies to the review. A useful record shows the time, dose, injection region, meal timing, and relevant activity. You do not need to reconstruct every moment perfectly; a few clearly recorded days can make the conversation more specific.
Diabetes UK’s injection-review checklist emphasizes inspecting sites and discussing technique. If an appointment has focused mainly on A1C, it is reasonable to ask explicitly: “Could you check my injection sites and watch how I use my pen?”
Why should changing sites come with a plan?
If you regularly inject into a lumpy area, contact your diabetes team promptly before changing your routine. Insulin may be absorbed more effectively when you move to unaffected tissue, increasing the risk of low glucose if the previous dose is continued without review.
The UK medicines regulator’s safety advice on insulin-site lumps specifically highlights careful monitoring and possible dose adjustment when moving away from an affected area. It also notes that not every lump is lipohypertrophy; a different condition called localized cutaneous amyloidosis can occur.
Do not independently choose a large dose reduction or increase. Ask where to inject, how often to check glucose during the transition, and what to do if readings fall or rise. If your usual team is unavailable, seek timely advice through your available diabetes service, prescriber, or pharmacist rather than improvising.
Want help preparing practical questions for your diabetes review? Explore WellNest Central’s health education and consultation services.
What does sensible rotation look like?
A rotation plan should be easy to follow and suited to the device and insulin you use. It may involve systematically moving between suitable points within an agreed region rather than choosing a spot at random each time.
Ask your team to mark out acceptable regions and explain spacing. Keep away from areas they identify as damaged, scarred, inflamed, or unsuitable. Use needles according to the device instructions and the training you have received. A new habit is easier to maintain when you understand the reason for each step.
For pump users, infusion-site care also matters. Follow the specific device’s instructions for changing infusion sets and locations; do not assume every pump has the same wear time. Diabetes UK’s pump information discusses site rotation and the need for a backup plan if a pump fails.
Consider keeping a simple body-region diagram with your supplies. The purpose is to avoid unconsciously returning to a favorite small patch. Review the system if it becomes confusing, uncomfortable, or impractical around work and exercise.
When should a lump be checked more urgently?
Seek prompt assessment if an area becomes red, hot, increasingly painful, drains fluid, or is accompanied by fever. A new or persistent lump should be examined rather than automatically labeled an insulin effect.
For severe hypoglycemia with confusion, seizure, or inability to swallow safely, another person should use prescribed rescue glucagon if available and call 911 in the United States. Do not give food or drink to someone who cannot swallow safely. Keep your individual low-glucose plan available to the people around you.
Persistent high glucose, vomiting, abdominal pain, or rapid breathing can also require urgent care. Follow your team’s ketone and sick-day instructions. Our article on ketone testing provides background on why symptoms and insulin delivery matter alongside glucose readings.
What should you leave the appointment knowing?
- Whether the lump is likely related to injections or needs further assessment.
- Which areas to avoid and which areas are suitable.
- Whether the insulin dose needs clinician-directed adjustment.
- How to monitor during the change and when to contact the team.
- When the injection sites should be reviewed again.
An effective review addresses both the skin and the glucose pattern. Small practical changes can matter, but they work best as part of an agreed diabetes plan.
For help organizing questions before that review, book a health education consultation.
